Vaxxinova’s acquisition of Deltamune’s operations in South Africa

Lead party: Vaxxinova International B.V. (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: Deltamune (Pty) Limited (private company) · Sector: Healthcare, Pharmaceuticals, Biotechnology · Countries of operation: South Africa Transaction type: Merger/Acquisition(M&A), Exit · Asset class: Private Equity, Corporate Transactions · Strategy: Secondary Sale · Instrument: Equity Lead…


Lead party: Vaxxinova International B.V. (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: Deltamune (Pty) Limited (private company) · Sector: Healthcare, Pharmaceuticals, Biotechnology · Countries of operation: South Africa

Transaction type: Merger/Acquisition(M&A), Exit · Asset class: Private Equity, Corporate Transactions · Strategy: Secondary Sale · Instrument: Equity

Lead investor/buyer: Vaxxinova International B.V. · Investors/buyers: Vaxxinova International B.V. · Sellers: Phatisa Group Limited

Legal advisers: not identified in the source record.

Source: announced 9 July 2025. Original announcement: phatisa.com.